Gleevec
Gleevec ingredients
| Active ingredient | Strength |
|---|---|
| Imatinib Mesylate | 100 mg/1, 400 mg/1 |
What Gleevec is used for
The FDA lists the approved uses on the official label (below). In the EU, imatinib is approved as Glivec for:
Glivec is indicated for the treatment of adult and paediatric patients with newly diagnosed Philadelphia-chromosome (bcr-abl)-positive (Ph+) chronic myeloid leukaemia (CML) for whom bone-marrow transplantation is not considered as the first line of treatment; adult and paediatric patients with Ph+ CML in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis; adult and paediatric patients with newly diagnosed Philadelphia-chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) integrated with chemotherapy; adult patients with relapsed or refractory Ph+ ALL as monotherapy; adult patients with myelodysplastic / myeloproliferative diseases (MDS / MPD) associated with platelet-derived growth factor receptor (PDGFR) gene re-arrangements; adult patients with advanced hypereosinophilic syndrome (HES) and / or chronic eosinophilic leukaemia (CEL) wit…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Gleevec
- Generic name
- Imatinib mesylate
- Made by
- Novartis Pharmaceuticals Corporation
- Forms
- Tablet
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA021588
- On the US market since
- 2001
Official information
- Gleevec prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Imatinib mesylate)
In India
- Imatinib mesylate: 68 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Gleevec?
Gleevec (Imatinib mesylate) is a cancer medicine made by Novartis Pharmaceuticals Corporation, approved by the US FDA.
What are the ingredients of Gleevec?
Gleevec contains Imatinib Mesylate (100 mg/1, 400 mg/1).
Is Gleevec approved in Europe?
The same active substance is approved in the EU as Glivec.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA